论文部分内容阅读
目的观察华佗再造丸联合丁苯酞胶囊治疗缺血性脑卒中的临床疗效。方法82例脑卒中患者随机分为观察组和对照组,观察组口服华佗再造丸和丁苯酞胶囊;对照组口服维脑路通片和川芎嗪注射液静脉注射,两组各用药1个月后进行神经功能缺损评分和疗效评价,并评价其预后。结果神经功能缺损评分ESS,治疗前两组比较差异无统计学意义(P>0.05),治疗后两组比较差异有统计学意义(P<0.05);观察组总有效率明显高于对照组(P<0.01)。结论华佗再造丸联合丁苯酞胶囊治疗缺血性脑卒中安全有效。
Objective To observe the clinical effect of Huatuo Zaizao Pill combined with butylphthalide capsule in the treatment of ischemic stroke. Methods Eighty-two stroke patients were randomly divided into observation group and control group. The observation group was treated with Huatuo Zaizao Pills and butylphthalide capsules. The control group was treated with intravenous injection of Venoruton and Ligustrazine injection for one month After neurological deficit score and efficacy evaluation, and evaluate the prognosis. Results The neurological deficit score ESS had no significant difference between the two groups before treatment (P> 0.05), and there was significant difference between the two groups after treatment (P <0.05). The total effective rate in the observation group was significantly higher than that in the control group P <0.01). Conclusion Huatuo Zaizao Pills and butylphthalide capsules are safe and effective in treating ischemic stroke.